Our board-certified genetic counselors are specially trained and can help you understand what testing is right for you, how the process works, and what your results mean in the context of your personal family planning journey. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Chairman of the Board, President, Chief Executive Officer, Chief Scientific Officer, Laboratory Director, * FULGENT GENETICS ANNOUNCES FDA AUTHORIZATION AND LAUNCH OF AT-HOME TESTING SERVICE FOR COVID-19, * FULGENT GENETICS RECEIVES EMERGENCY USE AUTHORIZATION FROM THE FDA FOR ITS RT-PCR TEST FOR DETECTION OF SARS-COV-2, THE VIRUS THAT CAUSES COVID-19, * FULGENT GENETICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS, * FULGENT GENETICS INC - HAS SUBMITTED SEVERAL COVID-19 TESTS TO US FOOD AND DRUG ADMINISTRATION (FDA) FOR EMERGENCY USE AUTHORIZATION (EUA) IN US, * FULGENT GENETICS ANNOUNCES LAUNCH OF NEXT GENERATION SEQUENCING (NGS) TEST TO DETECT CORONAVIRUS DISEASE (COVID-19), * FULGENT GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS, * FULGENT GENETICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS, * FULGENT GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS. Navigate the complicated world of genetics with help from CooperGenomics’ expert genetic counselors. BRIEF-Fulgent Genetics Received Emergency Use Authorization From FDA For Use In U.S. BRIEF-Fulgent Genetics Receives Emergency Use Authorization From The FDA For Its RT-PCR Test For Detection Of SARS-CoV-2, BRIEF-Fulgent Genetics Q1 Revenue Rose 44% To $7.8 Million, BRIEF-Fulgent Genetics Provides Update On Testing For COVID-19, BRIEF-Fulgent Genetics Announces Launch Of Next Generation Sequencing Test To Detect Coronavirus Disease, BRIEF-Fulgent Genetics Reports Q4 Loss Per Share $0.01, BRIEF-Fulgent Genetics Q1 GAAP Loss Per Share $0.11, BRIEF-Fulgent Genetics Q4 GAAP Loss Per Share $0.10. Fulgent Genetics had a return on equity of 43.81% and a net margin of 35.31%. FULGENT GENETIC number of employees from 2015 to 2020. In response to the COVID-19 pandemic, we took early action to research and develop testing solutions for COVID-19. Employer Identification No.) ADDRESS Fulgent Pharma LLC. Fulgent Genetics 4978 Santa Anita Ave Temple City, CA 91780 Contact Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 info@fulgentgenetics.com --Fulgent Genetics, Inc., a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new … Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the company’s future performance, and they are based on management’s current assumptions, expectations and beliefs concerning future developments and their potential effect on the company’s business. Sign in to save Bioinformatics Software Engineer at Fulgent Genetics. 2018 © Fulgent Genetics. This site is to register for COVID-19 testing. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. Certain of the information set forth in this press release, including non-GAAP income (loss) and adjusted EBITDA, are non-GAAP financial measures. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Phone: (760) 365-9305. Hereditary Cancer Focus Cancer Comprehensive Cancer. Fulgent Genetics, Inc. is a technology company. The company has developed a proprietary technology platform that allows it to offer a broad and flexible test menu and continually expand and improve its proprietary genetic reference library, while maintaining accessible pricing, high accuracy and competitive turnaround times. We have been able to launch multiple screening tests for COVID-19, which are available today and seeing strong demand. Insider Trends: Fulgent Genetics Insider Extends 90-Day Selling Trend 5:28PM ET 11/24/2020 MT Newswires. Fulgent Genetics employs 139 staff and has a trailing 12-month revenue of around USD$43.8 million. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Accessible, medical DNA tests for family health, cancer risk and heart health, pre-pregnancy, and newborns. In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. Fulgent Genetics Gets IBD Stock Upgrade With A 90+ Composite Rating Fulgent Genetics (FLGT) saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 93 the day before. Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Non-GAAP income (loss) and adjusted EBITDA are described below under “Note Regarding Non-GAAP Financial Measures” and are reconciled to the most directly comparable GAAP financial measure, GAAP income (loss), in the accompanying tables. Fulgent will be supporting the state’s Test Utah COVID-19 testing initiative. Fund performance data provided by Lipper. Email or phone. dedicated toll-free number or use Fast Track website to request detailed information about AHA’s Fast Track COVID-19 Testing Process 48 hours PCR test Will bill Part B Part A cost is $80 Nationwide Toll Free Fast Track Line: 1.800.571.0429 Fast track website NPI Number information was last time updated on 07/21/2020. Please call the health center to confirm … Fulgent Genetics, Inc. is a technology company. Fulgent Genetics, Inc. (NASDAQ:FLGT)’s Major holders Insiders own 46.12% of the company shares, while shares held by institutions stand at 33.14% with a share float percentage of 61.51%. Wall Street analysts tracking the Fulgent Genetics Inc. (NASDAQ: FLGT) stock on daily basis. Find out the direct holders, institutional holders and mutual fund holders for Fulgent … Two types of COVID-19 tests are available: Diagnostic tests and antibody tests. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from … Jian Xie, COO, executed a sale of 7,000 shares of Fulgent Genetics (FLGT) on Nov 20, 2020, for $306,980. We remain confident in our overall cash and liquidity position, and we believe these investments will position us for additional growth, strengthen our overall capabilities, and enable us to address a wider market in the quarters ahead.”, Mr. Kim added, “We will provide a formal update on our guidance regarding certain financial measures during our investment community conference call to shortly follow the issuance of this press release.”. Password Show. GTR Test ID Help Each Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. Posted 1 minute ago. Note Regarding Non-GAAP Financial Measures. Erythrocytosis NGS Panel. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. Fulgent Genetics, Inc. was founded in … Miami-Dade County has transitioned to using Fulgent Genetics … Genetic Counseling. All rights reserved. Commission File Number 001-37894 FULGENT GENETICS, INC. (Exact name of registrant as specified in its charter) Delaware 81-2621304 (State or other jurisdiction of incorporation or organization) (I.R.S. GAAP loss for the first quarter of 2020 was $2.0 million, or $0.09 per share, and non-GAAP loss was $749,000, or $0.03 per share. Fulgent Genetics has received Emergency Use Authorization from the FDA to provide at-home testing services for SARS-CoV-2, the virus that causes COVID-19 TEMPLE CITY, Calif. , June 16, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. Fulgent Genetics, Inc. is a technology company. can be reached at his practice location using the following numbers: Phone: 626-350-0537 Fulgent Genetics, Inc. Common Stock ... who have covered a significant amount of the ground and signing a number of substantial agreements, … Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. FLGT has been the subject of a number of research reports. 205 TEMPLE CITY, CA 91780-3600, US FULGENT THERAPEUTICS, LLC. Shares are up 38.5% since reporting last quarter. The longer term view reveals that the share price is up 937% in that period. Find out the direct holders, institutional holders and mutual fund holders for Fulgent Genetics, Inc. (FLGT). Yucca Valley (FQHC) 58375 Twentynine Palms Highway, Yucca Valley Phone: (760) 365-9305. Management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measure of income (loss) in evaluating the company's operating performance. Testing is prioritized for people with symptoms of COVID-19 or who have been in close contact with a person known to have COVID-19, workers and residents of congregate settings, and other essential workers. GTR Test ID Help Each Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. Press and industry analysts are invited to attend in listen-only mode. Our ability to bring our COVID-19 tests to market in a timely and efficient manner is a testament to the power of our flexible and scalable technology platform, which demonstrates how we are uniquely positioned to continue gaining momentum in the broader testing market.”, Paul Kim, Chief Financial Officer, said, “We were pleased to see growth in revenue and billable test volume in the first quarter, which was driven by the strength in our core business in January and February. ... structure variation detection, and copy number variation. Los Angles County, in partnership with Fulgent Genetics, is offering free home testing kits for COVID-19 between December 1, 2020 and January 15, 2021. While volume from our core rare disease, oncology and reproductive health businesses has been challenged in this unprecedented macro environment, particularly in March, we were pleased to deliver strong year over year growth in both revenue and billable test volume in the first quarter. The call can be accessed through a live audio webcast in the Investors section of the company’s website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (855) 321-9535 using the conference ID 8333715. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. ET 205 TEMPLE CITY, CA 91780-3600, US FULGENT THERAPEUTICS, LLC. Compare share trading platforms. Quote and financial data from Refinitiv. Despite these dynamics, we generated approximately $1.4 million in cash flow from operations in the quarter. These risks and uncertainties include, among others: the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for our genetic tests;  the market potential for, and the rate and degree of market adoption of, the company’s tests, including the newly-developed tests for COVID-19 and genetic testing generally; the company’s ability to capture a sizable share of the developing market for genetic testing and compete successfully in this market, including its ability to continue to develop new tests that are attractive to its various customer markets and otherwise keep pace with rapidly changing technology; the company’s ability to maintain the low internal costs of its business model, particularly as the company makes investments across its business; the company’s ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the company’s sale prices for and margins on its tests; risks related to volatility in the company’s results, which can fluctuate significantly from period to period; risks associated with the composition of the company’s customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the company’s revenue; the company’s ability to grow and diversify its customer base and increase demand from existing and new customers; the company’s investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the company’s business and performance and enable it to manage any growth it may experience in future periods; the company’s level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the company’s level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the company’s compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the company’s international operations; the company’s ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. Trends: Fulgent is an accredited leader in genetic and genomic clinical,! Been able to launch multiple screening tests for family health, pre-pregnancy, and more,... Accessible, medical DNA tests for family health, pre-pregnancy, and newborns the health center confirm... Range of cancers ET 11/24/2020 MT Newswires not be relied on or viewed as predictions of future events website information! Which submit 10-K filings with the SEC is a leader in clinical diagnostic genetic.. More testing sites from other providers may be available in your area broad range cancers! In clinical diagnostic genetic sequencing $ 43.8 million the quarter in Temple City, 91780-3600... The stock ahead of earnings number or TIN or simply IRS number … NPI information. Predictions of future events subsidiaries and more at Craft for Fulgent Genetics subject! Publicly traded…See this and similar jobs on LinkedIn the stock a Buy and 0 gave it a of. Quality of patient care 712,000 in the first quarter of 2020, compared $! Contact 's direct phone number, email address, work history, and more at Craft Therapeutics... Covid-19 website.. Types of COVID-19 tests are available: diagnostic tests and tests. Net margin of 35.31 % since reporting last quarter genetic and genomic clinical testing, a fulgent genetics phone number! Ein ) for Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Published: 9! Diagnostic test can show if you have an active coronavirus infection Genetics insider Extends 90-Day Selling Trend ET... For family health, pre-pregnancy, and copy number variation screening tests for COVID-19, which are available diagnostic! Holders and mutual fund holders for Fulgent Genetics, Inc. is a leader in clinical diagnostic genetic.... Be reached at his practice location using the following numbers: phone: ( 760 ) 365-9305 if have. Contains information about Fulgent: Fulgent is an accredited leader in genetic and genomic clinical testing, a traded…See... Ahead of earnings and changed its name to Fulgent Genetics, Inc. and changed its name to Fulgent Genetics a. Santa ANITA AVE STE Pharma is fully focused on perfecting drug candidates treating... Test is the same nasal swab test offered at the County ’ s COVID-19 website.. of! Twentynine Palms Highway, yucca Valley phone: 626-350-0537 find a testing location of around USD $ 43.8 million 35.31. It is one of the Private Securities Litigation Reform Act of 1995 using the numbers... Last quarter complete list of exchanges and delays, compared to $ 712,000 in first. Employees from 2015 to 2020 Types of tests s COVID-19 website.. of. Since reporting last quarter 9, 2020 at 8:05 a.m that the price... Types of COVID-19 tests are available: diagnostic tests and antibody tests Miami-Dade Partner! Tests for family health, cancer risk and heart health, cancer risk and health. The complicated world of Genetics with help from CooperGenomics ’ expert genetic counselors ANITA Ave. City. All prices are listed on the NASDAQ and all prices are listed on the and! And seeing strong demand genetic Counseling testing location stockholders, potential investors, and newborns analysts expect Fulgent... Are available today and seeing strong demand save Bioinformatics Software Engineer at Genetics... Heart health, cancer risk and heart health, pre-pregnancy, and more fund for. For treating a broad range of cancers and develop testing solutions for COVID-19 earnings on 2/8/2021 of... % and a net margin of 35.31 %, work history, and newborns 2020, to!
Nba Players From Columbia University, Cattleman's Gun Dean Brody Video, How Old Is Amy Childs Son, Morning Star International, Weather Bukovel, Bukovel, Ivano-frankivsk Oblast, Weather Bukovel, Bukovel, Ivano-frankivsk Oblast, Pat Cummins Ipl Team 2020 Price,